Public log · Updated July 3, 2026
Changelog
What we've changed, verified, and shipped on GLP-1 Picks.
- Every provider re-verification
- Every new article
- Every methodology update
Reverse-chronological, append-only, public on day one. The long version of our editorial policy.
July 2026 · 5 entries
- July 3Article shipped
Medicare GLP-1 Coverage: Everything Changing in July 2026
Medicare GLP-1 coverage is NOW LIVE as of July 1, 2026. Here's who qualifies for the $50/month Bridge program, how to get prior auth, and whether the Bridge beats cash-pay (our 49-provider price audit).
- July 2Provider re-verified
Trimi Health review, re-verified
Trimi Health is a pricing-first pick with a reputation problem. The structure is genuinely strong: flat pricing across doses, consult and overnight shipping included, $99/mo semaglutide on the annual plan, a named medical director, and named pharmacies. But the third-party record…
- July 2Provider re-verified
Telos RX review, re-verified
Telos RX is too new to trust with a multi-month commitment. The pricing structure is genuinely good, flat across doses, $0 consult, free 2-day shipping, and cheap 12-month rates across four formats including sublingual drops and a microdose tier. But the company was about 10 week…
- July 2Provider re-verified
LivBody review, re-verified
LivBody is a known supplement brand renting telehealth machinery, and the rubric score, 2.9/10, the lowest we track, reflects how little of the GLP-1 program you can verify before paying. Credit where due: four named pharmacies with street addresses, a named medical group, consul…
- July 2Article shipped
Ozempic vs Wegovy (2026): Same Drug, $1,028 vs $1,349 List, Here's Which You Need
Verified April 2026: Ozempic and Wegovy are both semaglutide from Novo Nordisk. Ozempic ($1,028/mo list) is approved for type 2 diabetes at max 2mg. Wegovy ($1,349/mo list) is approved for weight loss at max 2.4mg (or 7.2mg HD). Both drop to $349/mo self-pay via NovoCare.
June 2026 · 14 entries
- June 30Article shipped
Medicare GLP-1 Coverage July 2026: $50/mo Wegovy + Zepbound Bridge Program Guide
Updated June 30, 2026 (launch day eve): Medicare Part D covers Foundayo, Wegovy, and Zepbound for weight loss starting July 1, 2026 via the Medicare GLP-1 Bridge program. Flat $50/month copay. 3.4 million beneficiaries eligible. Both oral pills (Foundayo and Wegovy tablet) are co…
- June 24Article shipped
Mounjaro vs Ozempic (2026): The Honest Head-to-Head Your Doctor Won't Have Time For
Mounjaro (tirzepatide) and Ozempic (semaglutide) are both FDA-approved only for type 2 diabetes, neither is approved for weight loss (that's their sister brands, Zepbound and Wegovy). In the first head-to-head trial, SURMOUNT-5, tirzepatide beat semaglutide for weight loss (−20.2…
- June 24Article shipped
GLP-1 for PCOS (2026): Ozempic, Wegovy & Cheaper Compounded Paths
GLP-1 medications like Ozempic and Wegovy can help PCOS because the syndrome is driven by insulin resistance, and these drugs improve insulin sensitivity, drive weight loss, and in trials restored menstrual regularity and raised natural-pregnancy rates. But here is the catch almo…
- June 22Provider re-verified
Embody review, re-verified
Embody works when you buy it right. The oral tirzepatide gum is a differentiator no major competitor matches, and the 6-month money-back guarantee is in writing. One decision shapes the whole experience: choose 'Embody Flat' at $299/mo at signup instead of the $149 promo, since t…
- June 22Article shipped
Oral GLP-1 Pills for Weight Loss (2026): Foundayo, Oral Semaglutide (Wegovy) & All Options
As of 2026, two FDA-approved oral GLP-1 pills exist for weight loss: Foundayo (orforglipron, 12.4% weight loss, $149/mo self-pay via LillyDirect, no fasting needed, approved April 1) and the Wegovy pill (semaglutide 25mg, 16.6% weight loss, $1,349/mo list price, requires 30-min f…
- June 19Article shipped
Compounded Semaglutide Ban (2026): FDA Crackdown Explained + 4 Legal Switch Options
Updated June 29, 2026: FDA issued 30 warning letters to telehealth companies June 15 for illegally marketing compounded GLP-1s. 503B permanent exclusion comment period extended to July 30, 2026 (from June 29 via FR 2026-12937). FDA proposed April 30 to permanently remove semaglut…
- June 17Article shipped
Wegovy vs Zepbound (June 2026): SURMOUNT-5 Head-to-Head, Wegovy HD, & Cost Comparison
Updated June 2026: SURMOUNT-5 head-to-head trial (NEJM): Zepbound 20.2% vs Wegovy 13.7% weight loss at 72 weeks. Wegovy HD (7.2mg, FDA-approved March 2026) closes the gap at 20.7%. Wegovy self-pay: $349/mo (NovoCare). Zepbound self-pay: $299-$449/mo (LillyDirect). Both $25/mo wit…
- June 16Article shipped
CagriSema 2026: Weight Loss Results, FDA Timeline & Why You Can't Buy It Yet
CagriSema (cagrilintide + semaglutide) lost 22.7% average body weight in adults with obesity (REDEFINE 1) and 13.7% in adults with type 2 diabetes (REDEFINE 2) over 68 weeks. Novo Nordisk filed its US application on December 18, 2025; an FDA decision is expected later in 2026 wit…
- June 16Article shipped
Foundayo vs Wegovy Pill (2026): 16.6% vs 12.4% Weight Loss, $149 vs $1,349/mo Self-Pay
Updated June 16, 2026: CVS Caremark removed Foundayo's new-to-market block June 1 (~25–30M commercial lives can now be covered); Zepbound becomes co-preferred Oct 1; Medicare GLP-1 Bridge covers Foundayo at $50/mo from July 1. Verified IQVIA launch data runs through Week 3 (1,390…
- June 11Article shipped
Medicare GLP-1 Bridge Enrollment Guide 2026: $50 Copay for Foundayo, Wegovy & Zepbound
Updated June 11, 2026: CMS released the official prior authorization request form (cms.gov/glp-1-bridge.pdf, June 8) revealing a key eligibility nuance, beneficiaries with OSA, MASH, T2D, or established CVD are NOT eligible for the Bridge (they route through regular Part D instea…
- June 10Article shipped
Retatrutide TRIUMPH-1 Results (May 2026): 30.3% Weight Loss, Phase 3 Primary Trial
Updated June 10, 2026 (ADA 2026 full dataset): Retatrutide Phase 3 program complete. Obesity (TRIUMPH-1): 28.3% weight loss at 80 weeks, 30.3% at 104 weeks, 65.3% achieved BMI <30. T2D (TRANSCEND-T2D-1): A1C −2.0%, weight −16.8%. Comorbidities (ADA June 2026): TRIUMPH-4 knee OA,…
- June 4Article shipped
Semaglutide Before and After: Weight Loss Results by Month
Clinical trials show 15–17% body weight loss with semaglutide over 68 weeks. Here's what to expect month by month, backed by data from the STEP trials.
- June 2Editorial / methodology
Provider count 48 → 49, FeelGood added
Added FeelGood (feelgoodmeds.com), a budget compounded-semaglutide telehealth platform ($149/mo starting injection, $249/mo oral tablet), scored 7.0 by the published methodology. Its LegitScript approval and money-back guarantee are genuine strengths; undisclosed state coverage a…
- June 1Provider re-verified
FeelGood review, re-verified
FeelGood earns a place in the budget tier on price and access: $149/mo starting for compounded semaglutide, a $249/mo oral tablet route, free shipping, no membership fee, a money-back guarantee, and LegitScript approval, a stronger trust signal than most cheap compounded shops ca…
May 2026 · 55 entries
- May 17Provider re-verified
Willow review, re-verified
Willow is a solid mid-tier compounded-only GLP-1 platform. At $299/mo compounded semaglutide (injectable or daily oral) and $399/mo compounded tirzepatide, pricing is above ultra-cheap options like Lemonaid Health but reflects real clinical oversight. The oral semaglutide daily t…
- May 17Provider re-verified
Sprout Health review, re-verified
Sprout Health suits buyers who want one dedicated point of contact through their whole titration, backed by published outcomes data. Go in with eyes open: the external review record is weak, so lean on the protections, $199 first month, cancel anytime, and a 30-day refund on unus…
- May 17Provider re-verified
Fridays review, re-verified
Fridays is the best choice for users with GLP-1 insurance coverage, the direct billing can bring costs down to $25-50/mo, which is unbeatable. The nutrition coaching adds genuine value for users who want more than just medication. Without insurance, the $249/mo price is harder to…
- May 17Provider re-verified
Ro review, re-verified
Ro is the safest bet for insured users who want brand-name GLP-1 medications from a trusted platform. The speed, insurance integration, and brand recognition are unmatched. The trade-off is no compounded options and high self-pay prices, if you don't have insurance coverage, plat…
- May 17Provider re-verified
TrimRx review, re-verified
TrimRx is the best value for one specific buyer: you want compounded semaglutide, you want it cheap, and you don't need extras. The $149/mo all-inclusive price, fast onboarding, and free replacement guarantee make it a standout in the budget compounded space. The trade-off is cho…
- May 17Provider re-verified
Enhance MD review, re-verified
Enhance MD is the smart budget choice for self-directed users who know what they want. The $49-first-month, $212/mo-ongoing entry for both medication types is competitive (wafers from $84/mo on the 6-month plan), and the combination therapy options are a unique bonus. First-timer…
- May 17Provider re-verified
MEDVi review, re-verified
MEDVi is the best option for needle-averse users who want a clear pathway from oral to injectable GLP-1 treatment. The micro-dosing options, sleek portal, and 2026 expansion to compounded tirzepatide (both injectable and oral tablet) plus brand-name Ozempic broaden the appeal, wi…
- May 17Provider re-verified
Sesame Care review, re-verified
Sesame Care is the most cost-effective path to a GLP-1 prescription for insured patients: $25 per consultation, no subscription lock-in, and the broadest FDA-approved brand-name menu in the low-cost tier (Wegovy pen and pill, Zepbound, Foundayo). Uninsured users who want one bund…
- May 17Provider re-verified
Strut Health review, re-verified
Strut Health owns the needle-free lane and backs it with a full menu: oral semaglutide from $99/mo, oral tirzepatide at $199/mo, and auto-refill injectables if you ever switch. The trade-off is bioavailability: oral compounded formats absorb less efficiently than injections, and…
- May 17Provider re-verified
Ivim Health review, re-verified
Ivim restructured into package pricing, sema at $900 for 12 months (plus $75 mandatory membership) works out to $150/mo all-in, which is competitive. Tirz at $1,600 for 12 months is $208/mo all-in. Klarna financing available. Best for users who can commit to 6-12 months upfront.
- May 17Provider re-verified
bmiMD review, re-verified
bmiMD trades on scale: 80,000+ customers and same-day physician consults give it a maturity newer platforms lack. Enter through the TAKEOFF $100-off 3-month plan (roughly $99/mo first month), and budget for the ongoing rate around $289/mo plus $29.99 shipping and the $50 post-app…
- May 17Provider re-verified
Hone Health review, re-verified
Hone Health is the most medically thorough option on this list, the 40+ biomarker panel is genuinely more comprehensive than any competitor's intake process. But the layered pricing ($65 + $149/mo + medication) makes it 2-3x the cost of focused weight-loss platforms. Best for pat…
- May 17Provider re-verified
Found review, re-verified
Found is the clear winner for insured patients. The insurance coordination service and GLP-1 coverage check are features most competitors simply don't offer, and the 10+ medication toolkit gives clinicians flexibility single-medication platforms can't match. Cash-pay at $129/mo i…
- May 17Provider re-verified
MyStart Health review, re-verified
MyStart Health delivers the thing it promises: a monthly rate that locks in and never rises with your dose, at a competitive $149-179/mo with unlimited access to a 600+ doctor network. It's cash-pay, compounded-only, and select-state; insured patients get more from platforms like…
- May 17Provider re-verified
AgelessRx review, re-verified
AgelessRx is genuinely different, the longevity medicine framework, microdosing protocols, and no-membership model set it apart from cookie-cutter GLP-1 platforms. The liraglutide + B12 at $149/mo (+ $50 oversight) is the value play. Semaglutide at $340/mo total is overpriced for…
- May 17Provider re-verified
Direct Meds GLP-1 review, re-verified
Direct Meds is the one-price, everything-included pick, $280/mo covering medication, consultations, shipping, and pharmacy fees, with a 4.6 Trustpilot rating across 7,500+ reviews behind it. Competitors sell the same medication for $100-150 less if budget leads your decision. For…
- May 17Provider re-verified
Fella Health review, re-verified
Fella's brand-name-only approach is a bold bet on quality over price. The 6-month money-back guarantee is one of the strongest in the industry and shows real confidence. At $165/mo with a year commitment, it's actually competitive for brand-name GLP-1 access. The men-only focus m…
- May 17Provider re-verified
Maximus review, re-verified
Maximus is the cheapest way to try GLP-1 therapy, the $79.99 microdose and $99.99 starter are unmatched, and the microdosing program for lower-BMI patients fills a gap nobody else serves. Go in with the full price map: real ongoing costs at standard dosing are $300+/mo once consu…
- May 17Provider re-verified
TMates review, re-verified
TMates gives you two distinct ways to buy: all-in compounded GLP-1s at $158/mo on the 12-month plan (or $249 month-to-month), and a $99/mo clinical service for brand Wegovy/Zepbound where your own pharmacy dispenses the drug. Know which model you're buying: the $99 tier covers th…
- May 17Provider re-verified
Mochi Health review, re-verified
Mochi Health is the best value play for patients planning to stay on GLP-1 long-term at therapeutic doses. The flat $99/mo pricing saves real money compared to platforms that scale with dose. Four semaglutide formats and registered dietitian access are unique differentiators. The…
- May 17Provider re-verified
Elevate Health review, re-verified
Elevate Health's oral semaglutide at $114/mo is a standout price point, and the BNPL financing removes a real barrier for patients who can't afford $200+/mo upfront. Free blood work adds clinical value. The risk is promo-dependent pricing, lock in rates before enrolling and under…
- May 17Provider re-verified
DudeMeds review, re-verified
DudeMeds is the simplest GLP-1 platform to use: $199/mo all-in, 48-hour shipping, no appointments to schedule. The undisclosed company details (no public HQ, no founding date) are worth a question to support before you order, and first-timers who need guidance should look at plat…
- May 17Provider re-verified
Zealthy review, re-verified
Zealthy is built for insured patients. If the coordinators get your brand-name GLP-1 covered, you're looking at potentially $25/mo, value no cash-pay platform can touch, and multi-month supplies up to 12 months are a convenience most competitors can't offer. The company is young…
- May 17Provider re-verified
SynergyRx review, re-verified
The oral dissolving tablet format for both semaglutide and tirzepatide sets SynergyRx apart from most competitors, and free expedited shipping plus 24/7 support strengthen the package. Weigh that against limited reviews and an undisclosed company history, and get pharmacy partner…
- May 17Provider re-verified
PeterMD review, re-verified
PeterMD delivers genuine value at $165/mo flat with a semaglutide + B12 formulation that addresses the nausea problem most patients fear, backed by a 100,000+ patient base and strong Trustpilot reviews. The 42-state footprint and lack of BBB accreditation keep it from the top tie…
- May 17Provider re-verified
MangoRx review, re-verified
MangoRx owns a specific niche: oral-only GLP-1 with public-company accountability, and the NASDAQ listing is a genuine trust signal. At $299-399/mo for compounded oral tablets versus $99-179/mo injectable alternatives, you're paying a clear premium for the needle-free format, so…
- May 17Provider re-verified
Care Bare Rx review, re-verified
CareBareRX's flat $199/mo for both oral and injectable options is refreshingly straightforward, and the named physician leadership adds a trust layer most small platforms lack. The company publishes little about itself (no founding date, headquarters, pharmacy partners, or meanin…
- May 17Provider re-verified
Breeze Meds review, re-verified
The no-subscription model is BreezeMeds' main selling point: month-by-month ordering with no billing commitments, which suits patients burned by hard-to-cancel subscriptions elsewhere, and the three formulation options add real choice. Do your homework first: confusingly similar…
- May 17Provider re-verified
Hers review, re-verified
The 2026 Novo Nordisk partnership makes Hers materially different from where it was a year ago, FDA-approved Wegovy pen and pill from $149/mo is one of the cheapest brand-name GLP-1 routes available. Compounded semaglutide stays at $199/mo, and compounded tirzepatide and Zepbound…
- May 17Provider re-verified
Noom Med review, re-verified
Noom Med is the best choice for users who believe lasting weight loss requires behavior change alongside medication. The coaching methodology is research-backed and the integration with GLP-1s is thoughtful. At $249/mo without insurance, it's expensive if you mainly want the medi…
- May 17Provider re-verified
GobyMeds review, re-verified
GobyMeds is the best budget pick for compounded semaglutide in 2026. The $169/mo standard monthly rate (or $99/mo on the 3-month starter bundle), fast delivery, and strong user reviews make it a standout value. In 2026, GobyMeds expanded into tirzepatide and brand-name options, b…
- May 17Provider re-verified
Lemonaid Health review, re-verified
Lemonaid Health offers the credibility and medical rigor that comes with being one of the oldest telehealth platforms in the GLP-1 space. The physician-only prescribing and thorough intake process exceed most competitors. However, the $229/mo price for compounded medication is ha…
- May 17Provider re-verified
WeightWatchers (Sequence) review, re-verified
WeightWatchers' GLP-1 program makes sense for users who already love WW and want to add medication, or those with insurance who can bring the cost down. The community and structured approach add genuine value for the right user. But at $74/mo for the MED+ membership ($20/mo for t…
- May 17Provider re-verified
Calibrate review, re-verified
Calibrate in 2026 is cleaner and cheaper than it was, the $1,649 enrollment fee is gone, replaced by $199/mo with a 3-month commitment. You still get the structured physician-led program (labs, coaching, smart scale) plus a 10%+ weight-loss guarantee. Best for users who want clin…
- May 17Provider re-verified
GoodRx Care review, re-verified
GoodRx Care is a convenient prescription pathway for users already in the GoodRx ecosystem, especially those with insurance. The discount integration is genuinely useful for finding the cheapest pharmacy prices. But as a GLP-1 program, it's bare-bones, no ongoing support, no medi…
- May 17Provider re-verified
Shed review, re-verified
Shed is the fastest way to start GLP-1 treatment, 2-3 days from signup to medication delivery is genuinely market-leading, and the 4.6/5 Trustpilot score across 766 reviews says the speed doesn't come at quality's expense. At $199/mo for compounded semaglutide with tirzepatide al…
- May 17Provider re-verified
Gala review, re-verified
Gala earns its spot on two genuine strengths: the cheapest microdose tirzepatide tier on any tracked platform ($149/mo) and a dedicated tracker app on BOTH iOS and Android, a combination no other compounded-only platform matches. OpenLoop-affiliated medical groups and LegitScript…
- May 17Provider re-verified
Oak Longevity review, re-verified
Oak Longevity competes on price and billing freedom. $130/mo compounded semaglutide and $199/mo tirzepatide sit at the lower end of the market, the manual-renewal model means you're never auto-charged, and the broad menu (including a $100 oral Wegovy 4-week supply) gives users op…
- May 17Provider re-verified
Tonik Wellness review, re-verified
Tonik Wellness is a fair mid-tier compounded GLP-1 option with a clear strength (transparent six-tier monthly/quarterly/annual pricing on both semaglutide and tirzepatide) and a clear weakness (a 3-month minimum commitment plus final-sale rules that more flexible competitors like…
- May 17Provider re-verified
Novi review, re-verified
Novi is a credible upper-mid-tier compounded GLP-1 option with three clear strengths (six named clinicians, month-to-month billing with no commitment, aggressive $99-$133/mo introductory promo pricing) and the standard set of compounded-only weaknesses (no brand-name access, no o…
- May 17Provider re-verified
Wellorithm review, re-verified
Wellorithm earns its 7.4 with two genuinely uncommon features: compounded GLP-1 in oral dissolving tablet format alongside the standard injectable, and a 10% weight-loss money-back guarantee with up to four months of fees refundable if you don't hit the outcome target. Entry pric…
- May 17Provider re-verified
SkinnyRx review, re-verified
SkinnyRx wins on medication-format breadth: five compounded GLP-1 options across injectable, sublingual, and tablet formats, including the unusually rare oral tirzepatide tablet. The $199/mo entry tier matches the mid-tier compounded average, the 24–48h physician review and 3–7 d…
- May 17Provider re-verified
Bodybuilding Health+ review, re-verified
Bodybuilding Health+ pairs a competitively-priced compounded-GLP-1 menu ($179 sema, $209 tirz) with unusually good disclosure for its tier: a named medical advisor (Dr. Mark Rosenberg, M.D.) with verifiable anti-aging credentials, a disclosed operating entity (Dynamo Group LLC un…
- May 13Provider re-verified
Eden Health GLP-1 review, re-verified
Eden Health is the most clinically thorough GLP-1 platform we've reviewed, board-certified obesity medicine doctors and quarterly labs are real differentiators, and 4.5 stars across 3,777 Trustpilot reviews backs the customer-experience claim. Pricier than budget options like Hen…
- May 13Provider re-verified
Henry Meds review, re-verified
Henry Meds has the strongest verified customer-experience signal in our table, 12,461 Trustpilot reviews at 4.5 stars, 85% 5-star. Best for people who want a well-tested platform with the flexibility to switch between compounded and brand-name medications. The main transparency g…
- May 13Provider re-verified
Hims review, re-verified
Hims has the strongest brand recognition and one of the few direct Novo Nordisk partnerships for FDA-approved Wegovy. But the verified Trustpilot rating (3.0 across 8,286 reviews, 28% 1-star) is the weakest in our table, the lowest customer-experience signal among major affiliate…
- May 13Provider re-verified
Yucca Health review, re-verified
Yucca Health has the strongest customer-experience signal of any compounded GLP-1 provider we've checked: 4.6 stars across 1,065 Trustpilot reviews, two named board-certified doctors (rare in this category), and Klarna/Affirm/Afterpay financing to spread the 6-month plan. The $14…
- May 13Editorial / methodology
Publish-cadence cap announced
While at DR 0 with lifetime affiliate revenue below $500, new articles are capped at 2 per week. Every new article requires verified primary-source data, articles whose sources can't be independently checked are deferred, not shipped. The freed publishing capacity routes to revie…
- May 12Article shipped
IvyRx GLP-1 Review 2026: Flat-Rate Compounded Semaglutide & Tirzepatide at $175–$297/mo
IvyRx offers compounded semaglutide from $175/month and tirzepatide from $275/month with a rare flat-rate model, your price never increases as your dose goes up. We reviewed their pricing, clinical oversight, and transparency. Key finding: the flat-rate pricing is genuinely valua…
- May 12Editorial / methodology
Embody review v2, full verification pass
Re-verified Embody end-to-end via live-site crawl: pricing, medical director, compounding pharmacy partners, customer evidence, aggregate review scores. Six logical chapters with sticky TOC, plain-English methodology, no jargon. The template replicated weekly on the next click-wi…
- May 9Editorial / methodology
Provider Anchor audit script + GATE 3
Every reference to a provider's price across the codebase now traces to providers.ts. The audit script flags any drift between the canonical price and stale references in blog posts or components. Wired into the pre-push gate so price changes can't ship without consistency.
- May 8Article shipped
FDA Proposes Permanent 503B Compounding Ban for Semaglutide, Tirzepatide & Liraglutide
Verified May 8, 2026, Updated June 29, 2026: On April 30, FDA proposed permanently removing semaglutide, tirzepatide, and liraglutide from the 503B outsourcing bulk list, forever, not just during shortage enforcement. Public comment period extended to July 30, 2026 (from June 29…
- May 7Article shipped
Tirzepatide Dosage Chart for Weight Loss 2026: Complete Schedule (Zepbound, Mounjaro & Compounded)
Verified May 2026: Tirzepatide starts at 2.5 mg once weekly (non-therapeutic starter dose), escalates by 2.5 mg every 4 weeks to a maximum of 15 mg once weekly. Full escalation takes 20 weeks. At 72 weeks, the 15 mg dose produced 20.9% body weight loss in SURMOUNT-1, equivalent t…
- May 5Article shipped
Next Weight Loss Drugs Pipeline (2026): Retatrutide 28.7%, CagriSema 22.7%, MariTide Monthly
Updated May 2026: 5 next-gen obesity drugs in Phase 3. Retatrutide (Lilly) 28.7% weight loss. CagriSema (Novo): REDEFINE-1 22.7% (obesity), REDEFINE-2 15.7% (T2D), PDUFA expected October 2026. MariTide (Amgen, monthly), survodutide, Foundayo approved April 2026. FDA approvals 202…
- May 4Editorial / methodology
Scoring rubric 2026, published
Five-axis weighted methodology (Cost 25%, Clinical 25%, Medication options 20%, UX 15%, Insurance 15%) with public scoring-evidence.json. Every score traces to evidence flags; the build fails if a verified provider drifts from its computed score.
April 2026 · 23 entries
- April 29Article shipped
Foundayo (Orforglipron) Guide 2026: from $149/mo Self-Pay, 12.4% Weight Loss, No Fasting Required
Updated April 29, 2026: Foundayo (orforglipron) is the first non-peptide GLP-1 pill for weight loss, FDA-approved April 1, 2026. Produces 12.4% body weight loss over 72 weeks per ATTAIN-1 trial. ACHIEVE-4 (April 2026): 57% lower all-cause death vs insulin glargine (HR 0.43, 2,700…
- April 23Editorial / methodology
First affiliate conversion
Eden Health, $300 payout. Validated the funnel: organic search → review page → affiliate click → conversion. The unit economics check out; the bottleneck is volume, not the funnel.
- April 22Article shipped
Zepbound vs Mounjaro (April 2026): Same Drug, Different Labels, Which Is Right for You?
Verified April 2026: Zepbound and Mounjaro are the exact same drug (tirzepatide) at the same doses. Mounjaro was FDA-approved May 2022 for Type 2 diabetes. Zepbound was FDA-approved November 2023 for chronic weight management and December 2024 for obstructive sleep apnea. List pr…
- April 20Article shipped
Zepbound Side Effects (2026): Nausea 29%, Diarrhea 23%, Vomiting 13%, Full Guide with SURMOUNT Trial Data
Verified April 2026: Zepbound (tirzepatide) side effects from the SURMOUNT clinical trials, nausea affects 24-29% of patients (vs 8% placebo), diarrhea 19-23%, vomiting 8-13%. Only 4.3% discontinued at the highest dose. GI symptoms peak during dose escalation and resolve within 4…
- April 17Article shipped
GLP-1 Cost 2026: Wegovy, Zepbound & Ozempic Prices ($25–$1,350/mo)
How much do GLP-1 medications cost in 2026? Wegovy, Zepbound, Ozempic, Mounjaro & Foundayo range from $25–$1,350/month. With insurance + savings card: $25/mo. Without insurance: $146/mo compounded sema (Yucca Health), $149/mo Foundayo pill, $299–449/mo brand injectable (LillyDire…
- April 16Article shipped
RFK Jr. Proposes Medicare GLP-1 'Framework' (April 2026): Glucose Monitors First, Coverage Second
HHS Secretary Robert F. Kennedy Jr. is considering a regulatory framework for Medicare and Medicaid GLP-1 coverage, but only for patients who have 'exhausted other options', specifically glucose monitors (~$80/month), diet changes, and exercise. Verified April 2026: what Kennedy…
- April 13Article shipped
GLP-1 Receptor Agonists for Weight Loss 2026: FDA-Approved Options, Cost & Prescription Guide
FDA-approved GLP-1 receptor agonists for weight loss, 2026 guide. Eligibility: BMI 30+ (or 27+ with comorbidity). Semaglutide produces 14.9% weight loss (STEP-1), tirzepatide 20.9% (SURMOUNT-1). Cost: $25-$349/mo via telehealth. Complete 5-step prescription process with verified…
- April 11Article shipped
Brand vs Compounded GLP-1 (2026): $349 Wegovy vs $149 Compound, Legal Status + Safety
Verified April 2026: Brand-name Wegovy is $349/mo via NovoCare, Zepbound starts at $299/mo via LillyDirect. Compounded semaglutide is banned since Feb 2025; compounded tirzepatide remains legal at $149-299/mo under narrow medical-necessity rules. Full legal + safety comparison.
- April 11Article shipped
First Month on GLP-1 (2026): 2-5 lbs Lost Week 1-4, Nausea Peaks Week 4, Week-by-Week
Verified April 2026: GLP-1 patients lose 2-5 pounds in their first month. Appetite suppression starts week 1-2. Nausea peaks at week 4 dose escalation. 98.1% of GI side effects are mild-to-moderate per STEP-1 and SURMOUNT-1 trials. Complete week-by-week timeline with dosing sched…
- April 11Article shipped
Wegovy Pill vs Injection (2026): 16.6% vs 14.9% Weight Loss, $1,349 vs $349/mo
Verified April 2026: Oral Wegovy (25mg daily pill) produces 16.6% weight loss per the OASIS trial vs 14.9% for injectable Wegovy (2.4mg weekly) per STEP-1. Pill costs $1,349/mo list vs $349/mo self-pay for the injection through NovoCare. Full head-to-head comparison.
- April 11Article shipped
Semaglutide vs Tirzepatide (2026): 13.7% vs 20.2% Weight Loss, Head-to-Head SURMOUNT-5
Verified April 2026: Tirzepatide produces 20.2% weight loss vs semaglutide's 13.7% in the head-to-head SURMOUNT-5 trial (NEJM). Tirzepatide activates GLP-1 + GIP dual receptors; semaglutide activates GLP-1 only. Tirzepatide costs $449/mo vs $349/mo self-pay. Full comparison.
- April 11Article shipped
Foods to Avoid on GLP-1 (2026): 7 Worst Offenders + What to Eat Instead
Verified April 2026: The 7 worst foods on Ozempic, Wegovy, Zepbound, fried food, sugary drinks, red meat portions, raw cruciferous veg, carbonated beverages, alcohol, high-fiber bars. GLP-1s slow gastric emptying 25-40%, triggering nausea in 44% of patients. Full list with altern…
- April 11Article shipped
GLP-1 Side Effects (2026): Nausea 44%, Diarrhea 30%, Vomiting 24%, Complete Management Guide
Verified April 2026: 44% of Wegovy patients report nausea, 30% diarrhea, 24% vomiting in STEP-1 trial. Only 7% discontinued for side effects. Tirzepatide (Zepbound) is more tolerable: 24-33% nausea, 7-13% vomiting per SURMOUNT-1. Full management guide with red flags.
- April 11Article shipped
Tirzepatide Cost 2026: $149 to $1,086/Month, Every Option Ranked (Verified April 2026)
Verified April 2026: Tirzepatide costs $149/mo via Gala (compounded microdose), $299/mo via LillyDirect (brand Zepbound 2.5mg vial), $449/mo for LillyDirect 5mg+ vials, $25/mo with Zepbound savings card, or $1,086/mo retail list price. Full price breakdown with 47 verified provid…
- April 11Article shipped
Compounded Tirzepatide (2026): $149/mo Legal Options, Safety, Medical-Necessity Rules
Verified April 2026: Tirzepatide compounding enforcement began March 2025 after FDA removed it from the shortage list. Narrow medical-necessity exemptions still allow legal compounded tirzepatide at $149-300/mo (vs $1,086/mo retail Zepbound). Complete legal framework, safety, and…
- April 11Article shipped
Zepbound & Mounjaro Savings Card (2026): $25/mo Copay + $1,300 Annual Savings
Verified April 2026: Zepbound savings card cuts copay to $25/fill ($1,300 max annual savings) with commercial insurance. Mounjaro savings card offers $25 copay for T2D. Both expire Dec 31, 2026. Activate in 2 minutes at zepbound.lilly.com/savings. Full eligibility + backup option…
- April 11Article shipped
Foundayo Ships Week 2: How to Order Eli Lilly's GLP-1 Pill Right Now (April 2026)
Verified April 11, 2026: Foundayo (orforglipron) shipped to LillyDirect patients starting April 6. First-week fill rate hit 94% within 48 hours of order. Pricing confirmed: $649/mo self-pay, $25/mo with commercial insurance + Lilly savings card. Here's exactly how to order today.
- April 11Article shipped
FDA Issues 14 New GLP-1 Compounder Warning Letters (March-April 2026 Enforcement)
Verified April 11, 2026: The FDA issued 14 new warning letters to GLP-1 compounders between March 12 and April 8, 2026, the largest enforcement wave since the semaglutide compounding ban. Full list of affected pharmacies, what they violated, and what to do if you were a patient.
- April 10Editorial / methodology
Canonical tags on every page
Next.js App Router does not emit canonicals automatically from metadataBase, every route now explicitly exports alternates.canonical via metadata or generateMetadata. GATE 4 enforces this pre-push for any new template.
- April 10Editorial / methodology
Provider count 40 → 46 → 48
Expanded coverage to include Yucca Health, Gala, Embody, Bodybuilding Health+, and others. Every comparison page is template-generated, so n × (n-1) / 2 matchups stay in sync automatically.
- April 8Article shipped
GLP-1 Patches for Weight Loss: Do They Actually Work? (2026 Fact Check)
GLP-1 patches sold online don't contain semaglutide or tirzepatide, they're herbal supplements. Here's what the science says and what actually works.
- April 3Article shipped
Ro vs Hims for GLP-1 Weight Loss: Which Is Better in 2026?
Two of the biggest telehealth platforms now offer branded Wegovy and GLP-1 programs. We compare Ro and Hims on pricing, medications, insurance, clinical support, and what actually changed after the Novo Nordisk lawsuit.
- April 2Article shipped
Foundayo (Orforglipron) FDA Approved: The First GLP-1 Weight Loss Pill You Can Take Anytime
The FDA just approved Eli Lilly's Foundayo (orforglipron), the only GLP-1 weight loss pill with no food, water, or timing restrictions. Here's what it costs, how it works, and how it compares to Wegovy and Zepbound.